COLCORONA Trial Tests Anti-Inflammatory Drug for COVID-19
NYU Langone’s Dr. Binita Shah discusses a clinical trial that aims to see if colchicine can reduce complications for coronavirus patients.
Collaborations Expand the Landscape of Lupus Clinical Trials
NYU Langone Health experts conduct clinical trials to improve treatments for people with systemic lupus erythematosus (SLE) and lupus nephritis.
Collaborative Care in the Time of COVID-19
David Lat’s recovery from severe coronavirus disease highlights the power of teamwork at NYU Langone.
Collaborative Efforts Expand Brain Tumor Treatment Options
NYU Langone clinicians are developing genetically based cancer screens and expanding minimally invasive brain tumor treatment options.
Colorectal Cancer Cases Are Rising in Younger Adults
Dr. Shun Yu, a medical oncologist at NYU Langone’s Perlmutter Cancer Center, discusses the importance of screening for colorectal cancer.
Colorectal Cancer Facts & Figures
Find out more about colorectal cancer, including diagnosis and survival rates and its screening and treatment.
Combating Pancreatic Cancer by Starving Tumor Cells
Researchers at NYU Langone have identified an alternate food supply for pancreatic cancer tumors that promises more effective therapies.
Combatting the Side Effects of Atrial Fibrillation Treatment
Meds prescribed after Arlene’s A-fib treatment unfortunately came with serious side effects, but NYU Langone’s Heart Rhythm Center had a solution.
Combination Immune Therapy for Hodgkin Lymphoma
NYU Langone study shows new drug combinations can safely destroy most cancer cells in people with recurrent Hodgkin lymphoma.
Combination of Vaccine & Immunotherapy Counters Melanoma
NYU Langone researcher Dr. Jeffrey S. Weber led a clinical trial that found adding a vaccine to an immunotherapy reduced melanoma recurrence.